Serina Therapeutics
Serina Therapeutics is a privately-held pharmaceutical company that is advancing novel therapeutics for cancer, inflammation, pain, and metabolic disorders using its proprietary polymer technology. They have created new pharmaceutical candidates using polyoxazoline (POZ), a safe, water-soluble polymer to which they can attach a variety of small molecules, proteins, peptides, and DNA. The attachment of these molecules to polymers of POZ typically confers a unique pharmacokinetic profile that is markedly different from the parent compound, and this profile may confer advantages in terms of safety and efficacy.
Domain
serinatherapeutics.com
Country
United StatesIndustry
BiopharmaEmployees
1-10
Last Funding
$5.0M
Founded
2006
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Serina Therapeutics use?+
Serina Therapeutics uses 12 technologies including Sentry, Wix, GSAP.
What industry is Serina Therapeutics in?+
Serina Therapeutics operates in the Biopharma industry.
Where is Serina Therapeutics based?+
Serina Therapeutics is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026